The global creatinine measurement market is expected to reach USD 564.5 million by 2023 from USD 377.2 million in 2018, at a CAGR of 8.4%. This market is experiencing significant growth due to increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and increasing number of drug development initiatives.
Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=206847385
The creatinine measurement market is segmented on the basis of type, type of sample, end user, product, and region. By type, the market is segmented into Jaffe’s kinetic method and enzymatic method. The enzymatic method segment is expected to witness the highest CAGR over the forecast period owing to the increasing demand for more accurate methods for creatinine measurement and the increasing adoption of this method in developed regions.
The creatinine measurement market, by type of sample is segmented into blood/serum samples and urine samples. The blood sample segment is expected to witness the fastest growth over the forecast period due to the increased accuracy and low risk of contamination. Moreover, it is the most preferred sample type for accurate measurement of creatinine levels.
Based on end user, the creatinine measurement market is segmented into hospitals and diagnostic laboratories. The diagnostic laboratories segment is expected to witness the highest growth over the forecast period owing to increasing base of health-conscious population who undertake regular body function tests as a part of preventive healthcare and rising focus of various market players to increase their presence in the creatinine test kits and reagents market by entering into long term collaborations with diagnostic laboratories.
Based on product, the creatinine measurement market is segmented into reagents and kits. In 2018, the reagents method segment is expected to account for the largest share of the creatinine measurement market due to the increased accuracy and sensitivity for rapidly detecting the creatinine values in clinical samples. The reagent segment is also expected to witness the fastest growth over the forecast period, as various market players are providing reagents specific to their analyzers to gain a stable position in the creatinine measurement market.
Among the four regional segments covered in the creatinine measurement market—North America, Europe, Asia, and the Rest of the World (RoW), North America is estimated to account for the largest share of the global creatinine measurement market in 2018. Asia is expected to grow at the highest CAGR during the forecast period. The markets in Asian countries are driven by factors such as the growing prevalence of CKD, rising awareness towards preventive healthcare, improving healthcare infrastructure, and growing focus of market players on addressing demands in these countries.
